# Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

> **NCT04030000** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Northwell Health**

## Conditions studied

- Uterine Carcinoma

## Interventions

- **DRUG:** Paclitaxel/Carboplatin
- **RADIATION:** Pelvic radiation therapy

## Key facts

- **NCT ID:** NCT04030000
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-20
- **Primary completion:** 2022-08-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** could not enroll anyone due to staff changes
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04030000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04030000, "Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04030000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*